Nasopharyngeal symptoms do not predict poor adherence to nCPAP treatment

H. R. Kreivi, J. Lehto, P. E. Brander (Helsinki, Hyvinkää, Finland)

Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Session: Clinical aspects of continuous positive airway pressure therapy
Session type: Thematic Poster Session
Number: 777
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. R. Kreivi, J. Lehto, P. E. Brander (Helsinki, Hyvinkää, Finland). Nasopharyngeal symptoms do not predict poor adherence to nCPAP treatment. Eur Respir J 2008; 32: Suppl. 52, 777

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nasopharyngeal symptoms do not increase during nasal CPAP treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Improved adherence with PAP therapy after switching from CPAP to bilevel for non-compliant OSA patients
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018




Initial acceptance and compliance to nasal CPAP in elderly patients
Source: Annual Congress 2009 - Sleep apnoea across the ages
Year: 2009


Effect of CPAP adherence on depression in OSA patient
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


CPAP usage patterns in OSA patients with suboptimal adherence
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Long-term nCPAP compliance in patients with OSAS with initial in-hospital adjustment of nCPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

Tolerability on nasal mucociliary clearance after long-term nCPAP treatment in severe OSAS patients
Source: Eur Respir J 2001; 18: Suppl. 33, 418s
Year: 2001

Does CPAP use reflect effective CPAP treatment?
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002

Long-term outcome of nCPAP therapy in sleep apnoea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Evaluation of CPAP treatment at 3 months as a tool to predict long-term compliance
Source: Eur Respir J 2005; 26: Suppl. 49, 724s
Year: 2005

Treatment of early undiagnosed airflow obstruction in patients of OSA on CPAP improves sleep quality and symptoms
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


Does chronic opioid use impact OSA diagnosis and response to treatment with CPAP?
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


Side effects and associated symptoms predict adherence to chronic noninvasive ventilation
Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation
Year: 2019

Nasal CPAP in the therapy of OSAS – does a closer patient guidance and support increase compliance?
Source: Eur Respir J 2005; 26: Suppl. 49, 707s
Year: 2005

Adherence and satisfaction with CPAP therapy among sleep apnea patients: telematic compared with conventional follow-up
Source: Sleep and Breathing Conference 2021
Year: 2021




Compliance of positive airway pressure therapy in patients with sleep related breathing disorder
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Persistent daytime hypercapnia predicts poor prognosis in OSAS undergoing CPAP therapy
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

Parental risk factors for poor adherence to controller therapy in asthmatic children
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007


The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Changes in the quality of life of pulmonary TB patients depending on the severity of bronchial obstruction when using standard antituberculosis therapy and inhaled bronchodilator therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 21s
Year: 2003